211 related articles for article (PubMed ID: 405672)
21. Genetic marker in the variable region of kappa chains of mouse anti-phosphorylcholine antibodies.
Claflin JL
Eur J Immunol; 1976 Sep; 6(9):666-8. PubMed ID: 826399
[TBL] [Abstract][Full Text] [Related]
22. Structural, functional, and idiotypic characteristics of a phosphorylcholine-binding IgA myeloma protein of C57BL/ka allotype.
Claflin JL; Rudikoff S; Potter M; Davie JM
J Exp Med; 1975 Mar; 141(3):608-19. PubMed ID: 46916
[TBL] [Abstract][Full Text] [Related]
23. Somatic mutation in a cultured mouse myeloma cell affects antigen binding.
Cook WD; Rudikoff S; Giusti AM; Scharff MD
Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1240-4. PubMed ID: 6803237
[TBL] [Abstract][Full Text] [Related]
24. Specificity of interactions of hapten side chains with the combining site of the myeloma protein MOPC 315.
Wain-Hobson S; Dower SK; Gettins P; Givol D; McLaughlin AC; Pecht I; Sunderland CA; Dwek RA
Biochem J; 1977 Aug; 165(2):227-35. PubMed ID: 921746
[TBL] [Abstract][Full Text] [Related]
25. The immune response of BALB/c mice to phosphorylcholine is restricted to a limited number of VH- and VL-isotypes.
Kocher HP; Berek C; Jaton JC
Mol Immunol; 1981 Dec; 18(12):1027-33. PubMed ID: 6801477
[No Abstract] [Full Text] [Related]
26. Specific H chain junctional diversity may be required for non-T15 antibodies to bind phosphorylcholine.
Feeney AJ; Clarke SH; Mosier DE
J Immunol; 1988 Aug; 141(4):1267-72. PubMed ID: 3135325
[TBL] [Abstract][Full Text] [Related]
27. Resonance Raman-spectroscopic studies of the hapten features involved in the binding of 2,4-dinitrophenyl haptens by the mouse myeloma proteins MOPC 315 and MOPC 460.
Kumar K; Phelps DJ; Carey PR; Young NM
Biochem J; 1978 Nov; 175(2):727-35. PubMed ID: 743221
[TBL] [Abstract][Full Text] [Related]
28. Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7 A.
Satow Y; Cohen GH; Padlan EA; Davies DR
J Mol Biol; 1986 Aug; 190(4):593-604. PubMed ID: 3097327
[TBL] [Abstract][Full Text] [Related]
29. The binding of 2,4,6-trinitrophenyl derivatives to the mouse myeloma immunoglobulin A protein MOPC 315.
Dower SK; Gettins P; Jackson R; Dwek RA; Givol D
Biochem J; 1978 Jan; 169(1):179-88. PubMed ID: 629744
[TBL] [Abstract][Full Text] [Related]
30. Structural basis for the specificity of phosphorylcholine-binding immunoglobulins.
Padlan EA; Davies DR; Rudikoff S; Potter M
Immunochemistry; 1976 Nov; 13(11):945-9. PubMed ID: 827496
[No Abstract] [Full Text] [Related]
31. IgG antibodies to phosphorylcholine exhibit more diversity than their IgM counterparts.
Gearhart PJ; Johnson ND; Douglas R; Hood L
Nature; 1981 May; 291(5810):29-34. PubMed ID: 7231520
[TBL] [Abstract][Full Text] [Related]
32. Kappa chain structure from a crystallized murine Fab': role of joining segment in hapten binding.
Rudikoff S; Satow Y; Padlan E; Davies D; Potter M
Mol Immunol; 1981 Aug; 18(8):705-11. PubMed ID: 6796825
[No Abstract] [Full Text] [Related]
33. The circular dichroism of phosphocholine-specific mouse hybridoma and myeloma proteins: unusual properties of the hybridoma protein 101.6G6.
Young NM; Williams RE; Claflin JL
Mol Immunol; 1985 Mar; 22(3):305-11. PubMed ID: 2582246
[TBL] [Abstract][Full Text] [Related]
34. Identification of heavy chain tyrosine 33 in the binding site of myeloma protein McPC 603 by paired label iodination.
Grossberg AL; Roholt OA; Pressman D
J Immunol; 1976 Jun; 116(6):1596-600. PubMed ID: 818315
[TBL] [Abstract][Full Text] [Related]
35. Somatic diversification of S107 from an antiphosphocholine to an anti-DNA autoantibody is due to a single base change in its heavy chain variable region.
Giusti AM; Chien NC; Zack DJ; Shin SU; Scharff MD
Proc Natl Acad Sci U S A; 1987 May; 84(9):2926-30. PubMed ID: 3106981
[TBL] [Abstract][Full Text] [Related]
36. A novel idiotopic determinant on phosphorylcholine-binding immunoglobulins restricted to isotype and allotype.
Cronkhite RI; Cerny J
J Immunol; 1986 May; 136(10):3729-33. PubMed ID: 3084641
[TBL] [Abstract][Full Text] [Related]
37. Proteolytic dissection of a hapten binding site.
Sen J; Beychok S
Proteins; 1986 Nov; 1(3):256-62. PubMed ID: 3130623
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of phosphorylcholine binding to antibodies using synthetic peptides.
Lai EH; Kabat EA; Meienhofer J; Heimer EP; Olson AJ; Lerner R
Nature; 1987 Jan 8-14; 325(7000):168-71. PubMed ID: 3808074
[TBL] [Abstract][Full Text] [Related]
39. Immunologic memory to phosphocholine. IV. Hybridomas representative of Group I (T15-like) and Group II (non-T15-like) antibodies utilize distinct VH genes.
Chang SP; Perlmutter RM; Brown M; Heusser CH; Hood L; Rittenberg MB
J Immunol; 1984 Mar; 132(3):1550-5. PubMed ID: 6420466
[TBL] [Abstract][Full Text] [Related]
40. Sequence variation among heavy chains from inulin-binding myeloma proteins.
Vrana M; Rudikoff S; Potter M
Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1957-61. PubMed ID: 417344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
